Abdominal Aortic Aneurysms in Hemodialysis Patients with Autosomal Dominant Polycystic Kidney Disease

Nephron ◽  
2001 ◽  
Vol 88 (2) ◽  
pp. 185-186 ◽  
Author(s):  
Akihiko Kato ◽  
Takako Takita ◽  
Mitsuyoshi Furuhashi ◽  
Yukitaka Maruyama ◽  
Akira Hishida
1996 ◽  
Vol 7 (11) ◽  
pp. 2483-2486
Author(s):  
R Torra ◽  
C Nicolau ◽  
C Badenas ◽  
C Brú ◽  
L Pérez ◽  
...  

Although cases of autosomal dominant polycystic kidney disease (ADPKD) associated with abdominal aortic aneurysm have been repeatedly reported in the literature, no systematic studies of the aortas of these patients have been performed. In the study presented here, a sonographic study of the abdominal aorta in 139 ADPKD patients and in 149 healthy family members was carried out. For both groups, an increase in aortic diameter related to age and sex, (being wider in men than women) was found. In ADPKD patients, neither a wider aortic diameter nor a higher prevalence of abdominal aortic aneurysms could be found in any age group. It was concluded that, although these patients are prone to develop aortic aneurysms because of hypertension and associated connective tissue disorders, the presence of abdominal aortic aneurysms should be questioned as a frequent feature of ADPKD.


2020 ◽  
Vol 2020 (12) ◽  
Author(s):  
Abdullah Rida Hindawy ◽  
Baraa Daboul ◽  
Ibrahem Hanafi ◽  
Sami Albitar

ABSTRACT Autosomal dominant polycystic kidney disease (ADPKD) is a systemic disease characterized by the formation of multiple cysts in several organs. The formation of aneurysms accompanying this disease is being increasingly reported in the literature, and mutations in PKD-1 and PKD-2 are suspected in this etiology. Although the association between ADPKD and multiple coronary arteries aneurysms (CAA) was reported several times, we are presenting a case with the combination of ADPKD, multiple giant CAAs, abdominal aortic aneurysms and a suspected intracranial aneurysm, which has never been reported. The asymptomatic presentation of these multiple aneurysms might support the recommendations for further diagnostic investigations in these patients.


2019 ◽  
Vol 12 (4) ◽  
pp. e228552
Author(s):  
Vivek Sood ◽  
Navin Pattanashetti ◽  
Krishan Lal Gupta ◽  
Raja Ramachandran

Splenic artery aneurysm (SAA) is rare, with risk of rupture especially if diameter is >2 cm. It is usually asymptomatic and detected incidentally on imaging either in young pregnant women or elderly cirrhotic patients. Extracranial vascular abnormalities known to be associated with autosomal dominant polycystic kidney disease (ADPKD) include ascending aortic aneurysms, dissections of coronary and vertebral arteries and rarely SAA. We describe a rare case of incidentally detected SAA in a patient with end stage renal disease due to ADPKD during evaluation of persistent gross haematuria, with no evidence of cranial or other extracranial aneurysms.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Shinya Nakatani ◽  
Kozo Nishide ◽  
Senji Okuno ◽  
Eiji Ishimura ◽  
Daijiro Kabata ◽  
...  

AbstractA massively enlarged kidney can impact quality of life of autosomal dominant polycystic kidney disease (ADPKD) patients. A recent in vitro study demonstrated that an allosteric modulator of the calcium sensing receptor decreases adenosine-3′,5′-cyclic monophosphate, an important factor for kidney enlargement in ADPKD. Therefore, the present study was performed to determine whether cinacalcet, a calcium sensing receptor agonist, suppresses kidney enlargement in hemodialysis patients with ADPKD. Alteration of total kidney volume together with clinical parameters was retrospectively examined in 12 hemodialysis patients with ADPKD treated at a single institution in Japan. In the non-cinacalcet group with longer hemodialysis duration (n = 5), total kidney volume had an annual increase of 4.19 ± 1.71% during an overall period of 877 ± 494 days. In contrast, the annual rate of increase in total kidney volume in the cinacalcet group (n = 7) was significantly suppressed after cinacalcet treatment, from 3.26 ± 2.87% during a period of 734 ± 352 days before the start of cinacalcet to − 4.71 ± 6.42% during 918 ± 524 days after initiation of treatment (p = 0.047). The present findings showed that cinacalcet could be a novel therapeutic tool for suppression of kidney enlargement in hemodialysis patients with ADPKD.


2014 ◽  
Vol 36 (1) ◽  
pp. 18-25
Author(s):  
Everton Fernando Alves ◽  
Luiza Tamie Tsuneto ◽  
Sandra Marisa Pelloso ◽  
Paulo Roberto Aranha Torres ◽  
Guido Luis Gomes Otto ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document